77 related articles for article (PubMed ID: 23794088)
1. Differential expression of STAT1 and IFN-γ in primary and invasive or metastatic wilms tumors.
Liu W; Zhang L; Wu R
J Surg Oncol; 2013 Sep; 108(3):152-6. PubMed ID: 23794088
[TBL] [Abstract][Full Text] [Related]
2. The expression of IL-6 and STAT3 might predict progression and unfavorable prognosis in Wilms' tumor.
Zhang LJ; Liu W; Gao YM; Qin YJ; Wu RD
Biochem Biophys Res Commun; 2013 Jun; 435(3):408-13. PubMed ID: 23665320
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
[TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-β1 in Wilms' tumor was associated with invasiveness and disease progression.
Zhang L; Liu W; Qin Y; Wu R
J Pediatr Urol; 2014 Oct; 10(5):962-8. PubMed ID: 24559573
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors.
Chetcuti A; Aktas S; Mackie N; Ulger C; Toruner G; Alkan M; Catchpoole D
Pediatr Blood Cancer; 2011 Dec; 57(6):950-7. PubMed ID: 21387540
[TBL] [Abstract][Full Text] [Related]
7. p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness.
Franken J; Lerut E; Van Poppel H; Bogaert G
J Urol; 2013 Feb; 189(2):664-70. PubMed ID: 23036984
[TBL] [Abstract][Full Text] [Related]
8. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
9. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
11. Increased tissue factor expression and poor nephroblastoma prognosis.
Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
13. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of survivin expression in Wilms tumor.
Basta-Jovanovic G; Radojevic-Skodric S; Brasanac D; Djuricic S; Milasin J; Bogdanovic L; Opric D; Savin M; Baralic I; Jovanovic M
J BUON; 2012; 17(1):168-73. PubMed ID: 22517713
[TBL] [Abstract][Full Text] [Related]
15. Synergistic expression of the CXCL10 gene in response to IL-1β and IFN-γ involves NF-κB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4.
Burke SJ; Goff MR; Lu D; Proud D; Karlstad MD; Collier JJ
J Immunol; 2013 Jul; 191(1):323-36. PubMed ID: 23740952
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
17. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
[TBL] [Abstract][Full Text] [Related]
20. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
